|Bid||58.90 x 900|
|Ask||59.79 x 800|
|Day's Range||59.19 - 60.55|
|52 Week Range||37.61 - 104.64|
|Beta (5Y Monthly)||1.63|
|PE Ratio (TTM)||2.00|
|Earnings Date||Feb 06, 2023 - Feb 10, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 02, 2021|
|1y Target Est||70.00|
Subscribe to Yahoo Finance Plus to view Fair Value for AZTA
Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of the Company's common stock. The ASR was entered into pursuant to the Company's previously announced $1.5 billion share repurchase authorization. In addition to the ASR, the Company intends to repurchase at least an additional $500 million in common stock over the next year.
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, which includes a presentation beginning at 3:30 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2022.